FAF
EW icon

Första AP-fonden’s Edwards Lifesciences EW Stock Holding History

Första AP-fonden’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-126,200
Closed -$10.8M – 185
2025
Q4 		$10.8M Sell
126,200
-2,800
-2% -$230K 0.06% 255
2025
Q3 		$10M Buy
129,000
+7,700
+6% +$602K 0.06% 276
2025
Q2 		$9.49M Sell
121,300
-900
-0.7% -$67.1K 0.06% 259
2025
Q1 		$8.86M Sell
122,200
-7,900
-6% -$565K 0.07% 261
2024
Q4 		$9.63M Sell
130,100
-3,900
-3% -$273K 0.07% 266
2024
Q3 		$8.84M Buy
134,000
+14,400
+12% +$1.05M 0.07% 287
2024
Q2 		$11M Sell
119,600
-26,500
-18% -$2.35M 0.1% 197
2024
Q1 		$14M Buy
146,100
+12,600
+9% +$1.06M 0.12% 172
2023
Q4 		$10.2M Buy
133,500
+14,700
+12% +$1.02M 0.1% 204
2023
Q3 		$8.23M Hold
118,800
– – 0.09% 232
2023
Q2 		$11.2M Sell
118,800
-6,100
-5% -$530K 0.12% 173
2023
Q1 		$10.3M Sell
124,900
-26,400
-17% -$2.08M 0.12% 180
2022
Q4 		$11.3M Sell
151,300
-31,800
-17% -$2.45M 0.13% 178
2022
Q3 		$15.1M Buy
183,100
+300
+0.2% +$28.9K 0.19% 112
2022
Q2 		$17.4M Sell
182,800
-2,700
-1% -$280K 0.23% 93
2022
Q1 		$21.8M Buy
185,500
+22,900
+14% +$2.57M 0.25% 76
2021
Q4 		$21.1M Buy
162,600
+14,100
+9% +$1.64M 0.21% 91
2021
Q3 		$16.8M Sell
148,500
-12,000
-7% -$1.37M 0.19% 110
2021
Q2 		$16.6M Buy
160,500
+26,200
+20% +$2.47M 0.2% 108
2021
Q1 		$11.2M Buy
134,300
+9,000
+7% +$761K 0.16% 147
2020
Q4 		$11.4M Buy
125,300
+17,900
+17% +$1.48M 0.17% 130
2020
Q3 		$8.57M Buy
107,400
+22,300
+26% +$1.74M 0.18% 124
2020
Q2 		$5.88M Buy
85,100
+14,300
+20% +$1.02M 0.15% 173
2020
Q1 		$4.45M Buy
+70,800
New +$5.11M 0.16% 172

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Första AP-fonden's EW Position: Q1 2026 in Review

Första AP-fonden sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 126,200 shares — an estimated $10.8M sold.

Första AP-fonden first reported a position in EW in Q1 2020 and held it in 24 quarters. The position peaked at $21.8M in Q1 2022. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Första AP-fonden reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
  • Första AP-fonden sold 126,200 Edwards Lifesciences shares in Q1 2026, an estimated $10.8M.
  • Första AP-fonden first reported a position in Edwards Lifesciences in Q1 2020 and held it in 24 quarters.
  • Första AP-fonden's Edwards Lifesciences position peaked at $21.8M in Q1 2022.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Första AP-fonden's 13F filing for Q1 2026.